Stratify Genomics Competitors and Similar CompaniesClear all
Stratify Genomics's competitors and similar companies include 3D Medicines and TOMA Biosciences.
 Stratify Genomics Stratify Genomics' flagship test, Prompt, evaluates a man’s genetic predisposition to prostate cancer. |  3D Medicines 3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs. |  TOMA Biosciences TOMA Biosciences is a company providing a sequencing solution to identify changes in the DNA of cancer tumors. | |
Founding Date | Founding Date N/A | Founding Date 2010 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Shanghai, CN HQ Singapore, SG Dubai, AE Fremont, US | Locations Holland, US HQ |
Employees | Employees 5 | Employees 70030% decrease | Employees 9 |
Funding | |||
Latest funding round | Latest funding round $ 2.2m (almost 7 years ago) | Latest funding round $ 140m (over 5 years ago) | Latest funding round $ 7.8k (over 7 years ago) |
Total funding raised | Total funding raised $ 2.2m | Total funding raised $ 281m | Total funding raised $ 12.3m |
For sources of this data, please see the company profile
View Company Profiles
3D Medicines
HQ
Shanghai, CN
Employees
700↓ 30% decrease
3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.
View companyTOMA Biosciences
HQ
Holland, US
Employees
9
TOMA Biosciences is a company providing a sequencing solution to identify changes in the DNA of cancer tumors.
View company